New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers.

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...

The team developed the treatment for Clostridioides difficile ... of new probiotic strategies for humans to treat C. difficile infections as an alternative to antibiotics and conventional fecal ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

The team developed the treatment for Clostridioides difficile ... of new probiotic strategies for humans to treat C.

Despite being an everyday necessity, nutrition is something of a black box. We know that many plant-based foods are good for us, but we don't always ...

In this randomized controlled trial, among hospitalized patients with a bloodstream infection, seven days of antibiotic ...

The team developed the treatment for Clostridioides difficile ... of new probiotic strategies for humans to treat C. difficile infections as an alternative to antibiotics and conventional fecal ...